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ABSTRACT
Ribosomal subunit biogenesis in eukaryotes is a
complex multistep process. Mrd1 is an essential
and conserved small (40S) ribosomal subunit syn-
thesis factor that is required for early cleavages in
the 35S pre-ribosomal RNA (rRNA). Yeast Mrd1
contains five RNA-binding domains (RBDs), all of
which are necessary for optimal function of the
protein. Proteomic data showed that Mrd1 is part
of the early pre-ribosomal complexes, and deletion
of individual RBDs perturbs the pre-ribosomal struc-
ture. In vivo ultraviolet cross-linking showed that
Mrd1 binds to the pre-rRNA at two sites within the
18S region, in helix 27 (h27) and helix 28. The major
binding site lies in h27, and mutational analyses
shows that this interaction requires the RBD1-3
region of Mrd1. RBD2 plays the dominant role in
h27 binding, but other RBDs also contribute
directly. h27 and helix 28 are located close to the
sequences that form the central pseudoknot, a key
structural feature of the mature 40S subunit. We
speculate that the modular structure of Mrd1 coord-
inates pseudoknot formation with pre-rRNA
processing and subunit assembly.
INTRODUCTION
Biogenesis of the eukaryotic small (40S) and large (60S)
ribosomal subunits is a complex multistep process that
requires a large number of non-ribosomal proteins and
many small nucleolar RNAs (snoRNAs) (1–3). The 5S
ribosomal RNA (rRNA) component of the 60S subunit
is transcribed by RNA polymerase III. The large
precursor-rRNA (pre-rRNA), transcribed by RNA poly-
merase I, contains the three remaining rRNAs, the 18S
rRNA of the 40S subunit and the 5.8S and 25/28S
rRNAs of the 60S subunit. The processing of the 50 part
of the pre-rRNA into a pre-40S subunit and the process-
ing of the 30 part into a pre-60S subunit are largely, but
not completely, independent (4).
In growing yeast cells, roughly 70% of the pre-40S
subunits are released co-transcriptionally from the
earliest detectable precursor (90S) (5,6). Separation of
the pre-40S and pre-60S subunits occurs when the RNA
polymerase I has transcribed well into the 25S region of
the gene, 100 s after initiation of transcription (5,6).
During this time window, the pre-rRNA is continuously
synthesized and folded, as well as assembled with many
proteins and some ribosomal proteins. In addition, the
many small nucleolar ribonucleoproteins (snoRNPs) ﬁnd
their speciﬁc locations within the pre-rRNA and perform
their modiﬁcations of the pre-rRNA (5). It is still
unknown how all these co-transcriptional events take
place within a dynamic pre-rRNP. However, it is evident
that the pre-rRNA has to fold in sequential intermediate
folds and assemble into intermediate pre-rRNP
complexes. Processing subcomplexes have been identiﬁed
and their order of association with the pre-rRNA studied
(7,8), and different sequential structures have been
observed in the electron microscope (6). Presumably, the
pre-rRNA has evolved to optimize the speciﬁc folds and
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assemblies, and it is furthermore reasonable to assume
that processing factors facilitate these structures to allow
coordination, minimize non-productive structures and
allow for quality control.
The box C/D U3 snoRNP has an essential role in
pre-40S processing, being required for three early cleav-
ages of the pre-rRNA, at positions A0–A2. These cleav-
ages deﬁne and liberate the 20S rRNA, contained in the
pre-40S subunit (9). The U3 snoRNP appears to be
involved in coordinating essential pre-rRNP structures
via its base pairing at several positions within the 50
external transcribed spacer (ETS) and at the 50 end of
the 18S rRNA (10–14).
Mrd1 is an essential RNA-binding protein involved in
the maturation of the small ribosomal subunits in
Saccharomyces cerevisiae (15). It contains ﬁve RNA-
binding domains (RBDs), whereas higher eukaryotic
homologues have six such domains (16). Mrd1 binds co-
transcriptionally to the pre-rRNA, and together with
many other factors, it is involved in processing of the
90S pre-ribosome, which will result in mature 40S
subunits (15,17). All of the individual RBDs are
required for optimal protein function, but they are of dif-
ferent importance (18). RBD3 and RBD5 are essential for
protein function, whereas RBD1, RBD2 and RBD4 are
non-essential, but growth defects of the individual dele-
tions range from mild (RBD4) to severe (RBD1) (18).
The presence of multiple RBDs and previous experimental
ﬁndings suggested that Mrd1 associates directly with the
pre-rRNA and participates in formation of processing
competent pre-rRNP structures. To assess the function
of Mrd1 further, we used in vivo ultraviolet (UV) cross-
linking and complementary DNA (cDNA) cloning (19) to
map potential RNA interactions of Mrd1. Mrd1 was
found to be associated with the pre-rRNA at two sites
within the 18S sequence, located close to the 30 side of
the universally conserved pseudoknot within the mature
18S rRNA structure. The location of the binding sites in
the pre-ribosome indicates that Mrd1 is involved in the
folding and/or restructuring of the pre-rRNA, leading to
formation of the central pseudoknot. This structure is
conserved throughout evolution and is a key feature of
the small ribosomal subunit. Analyses of RBD deletions
revealed that the N-terminal half of Mrd1 associates with
the major interaction site within the 18S sequence, and




TheMRD1 gene and theMRD1 RBD deletion genes were
genomically tagged at their 30 ends with either the
Calmodulin-TEV-Protein A (TAP) or the His6-TEV-
Protein A (HTP) epitopes by a one-step polymerase
chain reaction (PCR)-based gene integration (20).
The PCR fragments were made by ampliﬁcation of the
TAP tag from pBS1539 and the HTP tag from
the pBS1539/HTP or pBS1479/HTP vectors (19) ﬂanked
by MRD1- or RRP5-speciﬁc sequences. Strains
were veriﬁed by PCR and western blot. Conditionally
mutant strains (HisMX6-PGAL1-3HA-MRD1 and
HisMX6-PGAL1-3HA-RRP5) and 3HA epitope-tagged
strains (UTP10-3HA-His3MX6, UTP22-3HA-His3MX6,
UTP22-3HA-KanMX6 and RRP5-3HA-KanMX6) were
created by transformation with a PCR construct contain-
ing either the His3MX6-PGAL1-3HA, 3HA-His3MX6 or
3HA-KanMX6 gene cassettes with ﬂanking regions of the
target gene, and tested for glucose sensitivity or histidine
prototrophy and/or G418 resistance. The genotypes of the
strains used in this study are listed in Supplementary
Table S1.
To integrate an additional genomic MRD1 wt allele
under control of the GAL1 promoter into the RBD1,
RBD3 and RBD5 strains, the plasmid pRS406-
PGAL-HA-MRD1 was cut with StuI in the URA3 open
reading frame. Transformants were selected for uracil
prototrophy and tested for galactose-dependent HA-
MRD1 protein expression.
A PCR construct with 500 nt upstream the transcription
start site for MRD1, a BssHII and a BclI restriction site,
the HTP tag-klURA3 and a nuclear localization signal
was transformed together with SalI and KpnI cleaved
pRS316 to construct plasmid pAS001 via homologous re-
combination. The pAS001 plasmid was digested with
BssHII and BclI, and transformed into yeast together
with various MRD1-RBD PCR constructs ﬂanked by
pAS001-speciﬁc sequence creating pAS001/RBD1,
RBD12, RBD123, RBD23, RBD234, RBD34, RBD345,
RBD45 and RBD12345 (Figure 4A). The plasmids were
sequenced, and expression of HTP-tagged RBD domains
was veriﬁed by western blots.
Immunoﬂuorescence
Cells were ﬁxed in 4% paraformaldehyde at
room temperature for 30 min. The cells were treated
with zymolase, adhered to poly-L-lysine-coated coverslips
and dehydrated over night in 70% ethanol at 20C.
HTP-tagged Mrd1 protein segments were visualized
using rabbit anti-TAP (CAB1001, 1:200, Open
Biosystems) and anti-rabbit Alexaﬂuor-488-conjugated
secondary antibodies (Molecular Probes). The nucleolus
was identiﬁed using a mouse anti-Nop1 antibody
(MCA-38F3, 1:800, EnCor Biotech), and a secondary
goat anti-mouse antibody conjugated to Alexaﬂuor-647
(Molecular Probes). The DNA was visualized with
DAPI, which was present in the mounting agent.
UV cross-linking and cDNA cloning (CRAC)
Cross-linking and cloning of cDNAs was performed as
described previously (19). UV-cross-linking was either
performed in vivo with cells in Petri dishes in a
Stratalinker 1800 (Stratagene) or in vivo in culture
medium in the Megatron (UVO3) as described previously
(21). UV cross-linking and analysis of cDNAs (CRAC)
cDNA libraries were generated using adapter sequences
as described previously (21).
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Bioinformatics analysis of CRAC data
CRAC cDNA sequence libraries were generated using
Illumina HiSeq and MiSeq systems according to the
manufacturer’s procedures.
After quality ﬁltering, PCR duplicates were removed
using fastx_collapser (http://hannonlab.cshl.edu/fastx_
toolkit/), and random nucleotide information was stored
in the 50 adapter sequences of the reads. Reads were
aligned to the yeast genomic reference sequence
(ENSEMBL) using Novoalign 2.0.7 (www.novocraft.
com). Downstream analyses, including the pile-ups pre-
sented here, were performed using the pyCRAC tool
suite (available on request: sgrannem@staffmail.ed.ac.uk;
manuscript in preparation).
Sucrose gradient centrifugations
Sucrose gradient centrifugations were made essentially as
described previously (17). ASY082, 094, 111 and PLY178
with the plasmid pAS001/RBD123 were depleted for
either Mrd1 or Rrp5 in glucose for 7 h before extraction.
Tandem afﬁnity puriﬁcation of Mrd1-TAP/HTP,
"RBD1-TAP/HTP, "RBD3-TAP/HTP and
"RBD5-TAP/HTP
The TAP puriﬁcations were performed essentially as
described previously (22). The RBD1-TAP/HTP,
RBD3-TAP/HTP and RBD5-TAP/HTP strains were
depleted for endogenous Mrd1 for 6 h in glucose before
harvest. Cells were grown to OD600 1, washed in 1X
phosphate buffered saline and frozen in liquid nitrogen.
Cell pellets corresponding to 6 1010 cells each were
resuspended in 1 volume lysis buffer, TMN150 [50mM
Tris–HCl (pH 7.8), 150mM NaCl, 1.5mM MgCl2, 0.1%
Nonidet-P40 and 5mM beta-mercaptoethanol], contain-
ing 1X Complete Protease Inhibitor Cocktail, EDTA
free, (Roche) and lysed with 3 volumes Zirconia beads
(0.5mm, Thistle Scientiﬁc). The cell extracts were resus-
pended in 3 volumes lysis buffer and clariﬁed by centrifu-
gation (20min at 4600 r.p.m. and 20min at 14 000r.p.m.).
The pH was adjusted to 7.5 by 1M Tris–HCl (pH 8.8).
Extracts were incubated with 500 ml pre-equilibrated IgG
Sepharose 6 Fast Flow beads (GE Healthcare) for 1 h at
4C. Beads were washed three times in 10ml of TMN150,
resuspended in 500 ml of TMN150 buffer with 30U of
AcTEV (Invitrogen) and incubated for 2 h at 18C. The
solution was transferred to micro bio-spin chromatog-
raphy columns (BioRad) and the eluate collected. The
eluated samples were mixed with 500 ml of TMN150 con-
taining 4mM CaCl2 and incubated with 150 ml
pre-equilibrated Calmodulin Sepharose 4B beads
(GE Healthcare) for 2 h at 4C. The beads were washed
three times with 1ml of TMN150 with 2mM CaCl2.
The washed beads were transferred to micro bio-spin
chromatography columns and eluted with EGTA buffer
[5mM EGTA, 10mM Tris–HCl (pH 7.8) and 50mM
NaCl]. The proteins were precipitated with TCA and
20 mg glycogen, and half of the precipitated material was
run on a 4–12% NuPAGE gel and silver stained according
to the protocol for SilverQuest staining kit (Invitrogen).
The other half was subjected to sodium dodecyl sulphate–
polyacrylamide gel electrophoresis, in-gel digested using
trypsin (23) and analysed using LC-MS on a
LTQ-Orbitrap (Thermo Fisher Scientiﬁc) coupled to
high pressure liquid chromatography via a
nanoelectrospray ion source. The MS data were analysed
using MaxQuant (24) and proteins identiﬁed by searching
MS and MS/MS data using the MASCOT search engine
(Matrix Science, UK).
Immunoprecipitations (IPs)
Extracts from 25 OD600 units of growing cells were used
for tandem afﬁnity puriﬁcations. Strains ASY080-084 and
ASY105-110 were grown to OD600 1, and for each
strain, 25 OD600 units of cells were used for tandem
afﬁnity puriﬁcation as described in the previous section.
For strain ASY082-084, ASY107 and ASY110, expression
of endogenous Mrd1 was shut off in glucose for 6 h before
harvest. Puriﬁed proteins were resuspended in loading
buffer, separated in 4–12% NuPAGE gels and transferred
to Immobilon PVDF membranes (Millipore).
Immunoprecipitation (IP) of ribonuclease (RNase)-
treated protein complexes was done as described previ-
ously on extracts that were incubated with 50U of
RNaceIt (Stratagene) for 15 min at 37C before centrifu-
gation to clear the extracts.
For analysis of afﬁnity-puriﬁed U3 snoRNA and 35S
pre-rRNA, 25 OD600 units of cells from strains
ASY053-056 and PLY094 (wt Mrd1) were harvested, ex-
tracted and puriﬁed on IgG Sepharose 6 Fast Flow beads
as described previously. RNA was extracted with a
mixture of Guanidine thiocyanate and phenol, followed
by ethanol precipitation. The puriﬁed RNA was
analysed by northern blot hybridization.
Western blot analysis
Primary antibodies used were polyclonal rabbit anti-TAP
antibody (CAB1001, 1:5000, Open Biosystems), anti-HA
peroxidase monoclonal antibody (3F10, 1:500–1:1000,
Roche), polyclonal anti-Mpp10 antibody (1:10 000) (25),
Peroxidase-Anti-Peroxidase Soluble Complex (P1291,
1:5000, Sigma) and monoclonal anti-PGK1 antibody
(anti-phosphoglycerokinase 1: 22C5, 1:10 000, Molecular
Probes). Secondary antibodies used were polyclonal goat
anti-mouse- and swine anti-rabbit HRP-coupled
antibodies (1:1000–1:10 000, DakoCytomation), and imm-
unodetection was performed with ECL solution
(Amersham Biosciences).
Northern blot analysis
RNA was separated on 1.5% agarose-formaldehyde gels,
blotted onto Zeta-probe membranes (BioRad), UV
cross-linked and hybridized with 32P-labelled oligonucleo-
tide probes as described previously (17).
RNA–protein binding in vitro
The complete Mrd1 was expressed in Escherichia coli as a
GST fusion protein and puriﬁed on Glutathione-
Sepharose 4B beads (GE Healthcare). Speciﬁed parts of
the MRD1 gene were obtained by PCR using speciﬁc
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primers and genomic DNA as template. The gene frag-
ments were cloned into the pET-46 Ek/LIC vector
(Novagen) and expressed in E. coli. His-tagged proteins
were puriﬁed by afﬁnity chromatography (Ni-NTA
agarose, Qiagen), followed by gel chromatography on Hi
Load 16/60, size S-75 or S-200, Superdex (GE
Healthcare).
Deﬁned parts of the 35S pre-rRNA were obtained by
PCR, introducing a T7 promoter at the 50 end of each
PCR fragment. Central regions of 18S rRNA were
synthesized and cloned (Euroﬁns MWG Operon), before
PCR. 32P-labelled RNA was synthesized by T7 polymer-
ase in vitro. The RNA was puriﬁed on 4% denaturing
polyacrylamide gels. For in vitro binding, performed es-
sentially as described previously (26), 2–3 fmol of RNA
was heated at 60C for 15min in RNA buffer [20 mM
Tris–HCl (pH 7.5) 200mM KCl and 5mM MgCl2] and
allowed to cool to 20C during 5 min. The RNA was then
incubated with different concentrations of puriﬁed protein
in 20mM Tris–HCl (pH 7.5) 200mM KCl, 5mM MgCl2,
20% glycerol, 50 mg/ml transfer RNA and 10 mg/ml bovine
serum albumin, for 30min at 20C. The RNA–protein
mixtures were ﬁltered through nitrocellulose ﬁlters
(0.45 mm HA, Millipore), followed by three washes of
300 ml of RNA buffer. The fraction of bound RNA was
measured by Cerenkov counting.
RESULTS
Mrd1 is part of pre-ribosomal complexes, and RBD
deletions perturb these complexes
To assess whether Mrd1 is part of pre-ribosomal
complexes, we performed TAP puriﬁcations of
C-terminally TAP-tagged wt Mrd1 (Figure 1A). Mrd1-
HTP, which lacks the calmodulin-binding peptide used
in the second step of TAP puriﬁcation, served as a
control. Mass spectrometry analysis of complexes
puriﬁed from two individual experiments with wt
Mrd1-TAP showed enrichment for many known compo-
nents of the early 90S pre-ribosome or small subunit
processome. Figure 1B shows a list of the top 30
puriﬁed proteins listed after average peptide scoring
from the two experiments. The top hit was Rrp5, which
is involved in both 40S and 60S subunit maturation (27).
Six of the seven characterized UTP-A/t-Utp proteins
(Figure 1B, red), ﬁve of the six characterized UTP-B
proteins (Figure 1B, bold) and the UTP-C protein
Utp22 were included among the 30 top proteins. In
addition, we found four RNA helicases. Seven of the
proteins (Figure 1B, grey shadow) have previously been
identiﬁed as Mrd1-interacting proteins [Utp22, Rps1B,
Utp9 (28), Utp12 (29), Utp4, Pwp2 (17) and Nop9 (30)].
We conclude that Mrd1 is part of the 90S pre-ribosomal
complex.
Deletion of RBD3 or RBD5 (named RBD3 or
RBD5) has previously shown that RBD3 and RBD5
are essential for Mrd1 function, while deletion of RBD1
(named RBD1) results in severe growth defect and le-
thality at 37C (18). TAP puriﬁcations of the RBD3,
RBD5 and RBD1 mutants were compared with wt
Mrd1 (Figure 1A). The RBD1 protein showed distinctly
reduced association with high-molecular weight-interact-
ing proteins, including the prominent Rrp5 and Utp22
(Figure 1A, compare wt lane with 1). Minor changes
were observed in the protein composition of
pre-ribosomes puriﬁed with the RBD3 or RBD5
Mrd1 proteins (Figure 1A). These results show that the
RBD1, RBD3 and RBD5 Mrd1 proteins are
associated with pre-ribosomes. Consistent with this, all
three deletion versions of Mrd1 were associated with U3
snoRNA and 35S pre-rRNA as shown by co-puriﬁcation
(Supplementary Figure S1). The composition of the
pre-ribosomes containing RBD1, RBD3 and
RBD5 is, however, perturbed.
The TAP-puriﬁed pre-ribosomes were further analysed
by western blotting in strains where wt Mrd1, RBD1,
RBD3 or RBD5 were TAP tagged, and Rrp5
was C-terminally tagged with a 3HA epitope. The
co-puriﬁcation of Rrp5-3HA was dramatically reduced
in RBD1, as compared with wt, RBD3 and RBD5
(Figure 1C). The loss of Rrp5-3HA was not because of a
general collapse of pre-ribosomes in the presence of
RBD1, as there was no signiﬁcant change in co-
precipitation of Mpp10 with the RBD1 mutant Mrd1
(Figure 1C). In agreement with the pattern of migration
for co-puriﬁed proteins (Figure 1A), the large Utp22-3HA
and Utp10-3HA also showed reduced association with
RBD1, as compared with wt Mrd1 (Figure 1D).
We could not detect reciprocal loss of Mrd1
RBD1-13-Myc in western blot analyses of Rrp5 TAP-
puriﬁed proteins (data not shown). This may result from
differences in pre-ribosome stability in combination with
which TAP-tagged protein was used for precipitation of
pre-ribosomes. However, RBD1 clearly inﬂuences the
pre-ribosomes such that Rrp5-3HA is not associated
with the RBD1-TAP-puriﬁed complexes.
We investigated whether Mrd1 or RBD1 inﬂuences
recruitment of Rrp5 to pre-ribosomes. Sucrose gradient
centrifugation experiments showed that depletion of
Mrd1 did not inﬂuence the association of Rrp5-TAP
with pre-ribosomal complexes, and the reciprocal
depletion of Rrp5 did not lead to defects in association
of Mrd1-TAP with the pre-ribosome complexes
(Supplementary Figure S2). We conclude that Mrd1 and
Rrp5 are present in the same pre-ribosomal complexes but
are recruited independently. In addition, we could not
detect a defect in recruitment of Rrp5-3HA to 90S
pre-ribosomes in the presence of only RBD1
(Supplementary Figure S2, lower panel). This indicates
that Rrp5 and RBD1 are in the same pre-ribosomal
complex, but deletion of RBD1 reduced the stability of
pre-ribosomal complexes resulting in loss of Rrp5 during
puriﬁcation (Figure 1).
To test whether Mrd1 and Rrp5 interact directly or
through indirect protein–protein interactions within
pre-ribosomes, extracts were treated with RNase before
precipitation. The interaction between Mrd1 and Rrp5
was lost, showing it to be dependent on RNA
(Figure 1E). In addition, Mrd1 and Rrp5 did not
interact in a yeast two-hybrid test (data not shown),
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Figure 1. Mrd1 is part of pre-ribosomes, and deletion of RBDs perturbs the pre-ribosome. (A) Tandem afﬁnity puriﬁcation of Mrd1-TAP/-HTP
(wt), RBD1-TAP/-HTP, RBD3-TAP/-HTP and RBD5-TAP/-HTP cells resolved on a 4–12% Bis-Tris NuPAGE gel and were silver stained.
Bracketed region shows where RBD1-TAP exhibits reduced protein interaction. Arrows indicate position of Rrp5 and Utp22. (B) Table of the 30
top hit proteins puriﬁed with Mrd1-TAP based on average peptide scoring number after mass spectrometry from two sets of Mrd1-TAP puriﬁca-
tions. Grey boxes indicate previously identiﬁed Mrd1-interacting components [Utp22, Rps1B, Utp9 (28), Utp12 (29), Utp4, Pwp2 (17) and Nop9
(30)]. Red indicates t-UTPs/UTP-A complex proteins and bold UTP-B complex proteins. Proteins puriﬁed also with Mrd1-HTP were removed from
the list. (C) Anti-TAP IPs of Mrd1-TAP/Rrp5-3HA (wt), Mrd1-HTP/Rrp5-3HA (wt), RBD1-TAP/Rrp5-3HA, RBD3-TAP/Rrp5-3HA and
RBD5-TAP/Rrp5-3HA cells. Western blot analysis with anti-TAP (top), anti-HA peroxidase (middle) and anti-Mpp10 (bottom) antibodies.
(D) Anti-TAP IPs of Mrd1-TAP/Utp22-3HA (wt), Mrd1-HTP/Utp22-3HA (wt), RBD1-TAP/Utp22-3HA cells (top), Mrd1-TAP/Utp10-3HA
(wt), Mrd1-HTP/Utp10-3HA (wt) and RBD1-TAP/Utp10-3HA cells (bottom), and western blot analysis with anti-HA peroxidase antibodies.
(E) Anti-TAP IPs of Mrd1-TAP/Rrp5-3HA (wt-TAP) and Mrd1-HTP/Rrp5-3HA (wt-HTP) cells in the presence (+) or absence () of RNase
treatment of cell extracts before IP. Western blot analysis with anti-HA peroxidase antibodies.
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further arguing that their interaction is mediated by
pre-ribosomes.
Mrd1 interacts mainly with two regions of the
pre-rRNA within the 18S rRNA sequence
We wished to identify the pre-RNA sequences that
interact with Mrd1 in vivo and which Mrd1 domains are
responsible for the interactions. We therefore applied
CRAC (19). This technique accurately maps the RNA
binding site(s) for target proteins via tandem afﬁnity puri-
ﬁcation of the tagged protein and the identiﬁcation of
short cross-linked RNA fragments by cDNA sequencing.
Intact cells expressing Mrd1 with a C-terminal HTP tag
(His6-TEV-ProtA) or a conventional TAP tag (CBP-
TEV-ProtA) were rapidly chilled and harvested before
UV irradiation at 254 nm in a Stratalinker. During the
CRAC procedure, RNA fragments are 50 labelled with
[32P] allowing the cross-linking efﬁciency to be assessed.
Mrd1-HTP showed strong cross-linking to RNA and
good recovery during puriﬁcation (Figure 2A). In com-
parison, the TAP-tagged Mrd1 that bound to IgG
sepharose beads was, as expected, not retained on the
nickel column, showing that the labelled band indeed cor-
responds to Mrd1-HTP. RNA bound to puriﬁed Mrd1-
HTP was reverse transcribed and cloned, and random
clones were sequenced.
Twenty-seven of 28 cloned cDNAs were 18S rRNA
sequences. A total of 18 of the 27 sequences aligned at
one single region corresponding to helix 27 (h27) in the
Figure 2. UV cross-linking of Mrd1 to pre-rRNA revealed cross-linking of Mrd1 to two regions within the 18S sequence. (A) Five percent of the
TEV eluates and nickel eluates from Mrd1-HTP and Mrd1-TAP-tagged cells, detected by western blot analysis (upper panels). Autoradiogram (lower
panel) shows Mrd1-HTP cross-linked to radiolabelled RNA. The asterisk indicates frequently detected contaminants. (B) Alignment of the 18 cDNA
clones to the 18S sequence nucleotides 1124–1132. Red box indicates the Mrd1 binding sites and blue box the 18S sequence involved in base pairing
at the 30 side of the central pseudoknot. Substitutions and deletions are marked with red. (C) High-throughput sequencing revealed cross-linking of
Mrd1 to h27 and h28. Histogram showing the location of the Mrd1-HTP associated RNA fragment hits (y-axis) mapped to the 18S rRNA (x-axis).
(D) The Mrd1 binding sites (red within grey boxes) in h27 and h28 are shown for the mature secondary structure of the central region of 18S rRNA.
The location of the central pseudoknot (blue) is indicated. PDB numbers are 3U5B (RNA) and 3U5C (rproteins).
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mature RNA structure (Figure 2B and D). Each of the 18
sequences contained base alterations, either substitutions
or deletions, at positions 1126 and/or 1128 in the 18S
rRNA (Figure 2B), which identiﬁed the location of the
direct protein–RNA contacts (19). To identify potential
additional interactions, Solexa deep sequencing was per-
formed on CRAC-puriﬁed cDNA. This too revealed that
the dominant in vivo cross-linking site of Mrd1 is the h27
region (data not shown).
To search for further, less abundant or transient
RNA interaction sites for Mrd1, UV cross-linking was
performed on cells actively growing in culture medium
(21). After removal of PCR duplicates using random
barcode sequence information, a total of 141 422
unique cDNAs were identiﬁed. Ninety-two percent of
the reads could be aligned to genomic features, and of
these 105 956 reads mapped to the rRNA (correspond-
ing to 81%), and of those, 85 790 were found to align to
the 18S (81% of rRNA reads) (Figure 2C). The vast
majority of 18S reads (90%) again aligned to the es-
tablished h27 and contained deletions/substitutions at
positions 1126 and 1128 (44% at G1126 and 67% at
C1128).
Additional, minor interaction sites were also identiﬁed
(Figure 2C). The most prominent of these covered a
region centred around nucleotide 1635 within the 18S
rRNA. Hits to this region amounted to 6% of the fre-
quency at h27. The probable direct interaction site in this
region is within helix 28 (h28), at U1626 (44% of the reads
had substitutions/deletions at U1626). Although the
binding of Mrd1 at positions 1126–1128 and 1626 is
separated by 500 nt in the primary sequence, h27 and
h28 are located in close proximity to the mature 18S
secondary structure (Figure 2D).
RBD1, 3 and 5 of Mrd1 are individually dispensable for
18S rRNA h27 interaction
We next wished to establish which, if any, of the RBDs in
Mrd1 speciﬁcally mediate the pre-rRNA interactions. All
ﬁve RBD deletion constructs (RBD1–5) were
genomically C-terminally HTP tagged and tested for
RNA cross-linking (Figure 3). For the lethal and
severely growth-defective RBD deletions (RBD1,
RBD3 and RBD5), a PGAL1-HA-MRD1 gene was
inserted into the URA3 locus with a yeast
integrating plasmid containing the MRD1 allele
(pRS406/PGAL1-HA-MRD1). Before UV cross-linking
of the cells, the strains were transferred to glucose for
6 h to deplete wt Mrd1. The HTP-tagged Mrd1 RBD de-
letions were expressed at similar levels (Figure 3A, 5%
TEV input). The RBD1, 3, 4 and 5 mutant proteins
interacted with RNA with efﬁciencies similar to, or
greater than, intact Mrd1-HTP (Figure 3A, autoradio-
gram). The efﬁcient cross-linking observed especially for
the RBD3-HTP, RBD4-HTP and RBD5-HTP
mutants is probably a consequence of the stalled
pre-ribosomal complexes that these deletions induce (18).
We analysed the lethal or severely growth affected
RBD1-HTP, RBD3-HTP and RBD5-HTP mutant
strains with in vivo CRAC analysis. cDNA sequencing
from RBD1-HTP (20 clones), RBD3-HTP (70
clones) or RBD5-HTP (70 clones) revealed that in
each case, 70–80% of all hits aligned to the rRNA. The
Figure 3. UV cross-linking properties of Mrd1 deletion mutants, lacking RBD1, 3 or 5. (A) Five percent of the TEV eluates and nickel eluates from
Mrd1-HTP, Mrd1-TAP, RBD1-HTP, RBD2-HTP, RBD3-HTP, RBD4-HTP and RBD5-HTP cells detected by western blot analyses. The
autoradiogram (lower panel) shows the proteins cross-linked to radiolabelled RNA. (B) Schematic representation of Mrd1-HTP and the ﬁve
individual RBD deletion mutants indicated (C) Histogram of the RNA hits associated with Mrd1-HTP, RBD1-HTP, RBD3-HTP and
RBD5-HTP (y-axis) mapped to the 18S sequence, nucleotides 1080–1185 (x-axis). The Mrd1 binding site at h27 is indicated with an arrow.
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majority of these hits (62, 56 and 83% inRBD1, 3 and 5,
respectively) were located in 18S rRNA h27 (Figure 3C),
and also contained the substitutions or deletions at pos-
itions 1126 and 1128. We conclude that none of the func-
tionally important RBD1, RBD3 or RBD5 in Mrd1 is
individually responsible for interacting with the h27
sequence in 18S rRNA. This is probably also the case
for RBD4, as the RNA cross-linking efﬁciency remained
high for RBD4. Cross-linking for RBD2 was weak
and studied in detail later. We were not able to establish
whether any of the RBDs are responsible for h28 inter-
action, as we did not perform high-throughput sequencing
on the cDNA libraries from the deletion mutants.
The N-terminal half of Mrd1 is responsible for interaction
with the 18S rRNA h27
We wished to further analyse the RNA binding ability of
Mrd1 and what part of the protein that is responsible for
the 18S rRNA sequence interaction. For this purpose, the
protein was divided into fragments that included various
RBDs and a C-terminal HTP epitope. We constructed
plasmids containing the MRD1 promoter (a 500-bp
fragment upstream of the transcription start site),
various regions of the MRD1 ORF, a nuclear localization
signal and the HTP tag. Figure 4A shows schematically
the parts of MRD1 included in each construct. The HTP-
tagged parts of Mrd1 were all expressed, but at variable
levels (Figure 4B). All Mrd1 constructs containing RBD1
were more highly expressed than constructs lacking RBD1
(Figure 4B compare lanes 1–3 with lanes 4–8).
Immunoﬂuorescence localization of the expressed Mrd1
parts revealed that only RBD123 and wt full-length
Mrd1 (RBD12345) were localized predominantly to the
nucleolus as judged by co-localization with Nop1
(Figure 4C). All the other constructs (RBD1, RBD12,
RBD23, RBD234, RBD34, RBD345 and RBD45)
showed widespread immunolocalization signals in the
nucleus and cytoplasm (data not shown). RBD123 was
incorporated into pre-ribosomal complexes
(Supplementary Figure S3A) but did not support
cleavage of the pre-rRNA at sites A0–A2 (Supplementary
Figure S3B) or cell growth (data not shown).
We tested the in vivo RNA binding capacity of the more
highly expressed constructs containing RBD1
(RBD12-HTP and RBD123-HTP) together with the
full-length RBD12345-HTP. RBD123-HTP was UV
cross-linked to RNA with the same efﬁciency as the
full-length construct (Figure 4D). A total of 10 cDNA
clones were sequenced from the RBD123 construct, of
which eight contained the 18S rRNA h27 sequence with
Figure 4. The N-terminal part of Mrd1 is responsible for interaction of Mrd1 at h27. (A) Schematic ﬁgure of the RBD constructs in pRS316. All
constructs contained the nuclear localization signal and HTP regions at their C-terminus as shown for RBD12345. (B) Western blot analysis of the
protein expression of the RBD constructs visualized with Peroxidase-Anti-Peroxidase Soluble Complex (upper). Anti-phosphoglycerokinase 1 (lower)
served as a loading control. (C) Immunocytochemistry of RBD12345-HTP (top) and RBD123-HTP (bottom) constructs with anti-TAP (green) or
anti-Nop1 (red) antibodies and DAPI. (D) CRAC analysis of RBD12345-HTP and RBD123-HTP constructs.
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substitutions/deletions at positions 1126 and 1128. In
contrast, RBD12-HTP cross-linked to RNA with lower
efﬁciency, and none of 10 clones sequenced could be
mapped to the pre-rRNA (data not shown). The lack of
binding of RBD12-HTP to rRNA could be because of
disturbed localization of the construct in the cell.
RBD2 is required for efﬁcient cross-linking of
Mrd1 to h27
In Figure 3A, it was suggested that UV cross-linking to
RNA was reduced as a result of deletion of RBD2. To
analyse the importance of RBD2 in more detail, cells ex-
pressing wt Mrd1-HTP or RBD2-HTP were UV
irradiated while actively growing in SD growth medium,
and cross-linked RNAs were analysed by high-throughput
sequencing. For wt Mrd1, as in Figure 2C, the vast
majority of the interactions were at h27 with minor inter-
action at h28 (Figure 5A). Approximately 20-fold fewer
sequences were recovered for h27 in RBD2-HTP than
for wt Mrd1-HTP. This apparently reﬂects a speciﬁc
inﬂuence on the interactions at h27, which were greatly
reduced, whereas recovery of sequences from h28 was
slightly increased (3-fold), as compared with wt Mrd1
(Figure 5A). In consequence, the relative frequency of
interaction at h27 and h28 was reversed between wt and
RBD2-HTP. Among the residual h27 sequences
recovered with RBD2-HTP, mutations at positions
1126 and 1128 were less frequent (28 and 32% for
RBD2 compared with 42 and 76% in wt Mrd1),
strongly indicating that the residual interaction between
RBD2 and h27 differs in the speciﬁc RNA–protein
contacts compared with wt Mrd1. In contrast, the
mutation frequency at position 1626 in h28 was 52% for
RBD2 and 57% for wt Mrd1, consistent with unaltered
contacts in this region.
We conclude that RBD2 is required for efﬁcient cross-
linking of Mrd1 to h27, but is not responsible for inter-
action at h28. In the absence of RBD2, cross-linking at
h27 is however not completely absent. This indicates that
while RBD2 plays an important role in the interactions at
h27, other regions of Mrd1 also interact at this site.
The results for RBD2 underscore the positioning of
the Mrd1 interactions within the 18S region of the
pre-rRNA. In Figures 2D and 5B, the spatial relationship
between the interactions at h27 and h28 are highlighted in
relation to the mature fold of 18S rRNA. The interaction
sites in h27 and h28 are close to each other, and to the
central pseudoknot and the decoding centre.
In vitro RNA binding of Mrd1, RBD123 and RBD45
To complement the in vivo RNA binding results, we per-
formed RNA–protein binding in vitro, using RNA
Figure 5. RBD2 is important for Mrd1 association with h27. (A) High-throughput sequencing of CRAC cDNA library for wt Mrd1 and RBD2.
Histogram shows hits (y-axis) versus the position in 35S pre-rRNA (x-axis). h27 and h28 are denoted. (B) The modelled Mrd1 binding sites (red) of
nucleotides 1126 and 1626 are located and highlighted in the mature secondary structure of S. cerevisiae 18S rRNA. The location of small ribosomal
subunit proteins S13 (blue), S23 (light blue) and S26 (purple) are indicated as references.
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fragments corresponding to regions of the pre-rRNA
(Figure 6A), and full-length Mrd1 or parts of Mrd1 ex-
pressed in E. coli (see Supplementary Figure S4). Full-
length Mrd1 bound equally well to the 50 and middle
regions of 18S rRNA (nucleotides 1–600 of 18S and nu-
cleotides 577–1256 of 18S, respectively) with 30–35% total
binding and a Kd value of 20–30 nM. Signiﬁcantly lower
binding for full-length Mrd1 was seen for the 30 end of 18S
(nucleotides 1233–1796 of 18S), 50ETS, ITS1 and ITS2
(4–19%), while a region in 25S bound with similar
afﬁnity as the ﬁrst two-thirds of 18S (Figure 6B). As
full-length Mrd1 was GST tagged, we tested GST alone
for binding. GST did not bind any of the RNA fragments
(data not shown). To analyse whether the central region of
18S, including h27 and the central pseudoknot sequences,
confer binding to Mrd1 in vitro, we tested an RNA con-
struct containing only the central region of 18S rRNA
(18S central in Figure 6C). In this RNA, h27 and h28
are present, but most of the surrounding 50 domain, 30
major domain and part of the central domain of 18S
rRNA were not included. Mrd1 bound to this construct
to a similar level as to the middle region of 18S (also
containing h27) and with similar Kd value (Figure 6B
and D). We tested two mutant versions of the central
region of 18S (Figure 6C). Deletion of h27 (18S central
h27) resulted in reduced binding to Mrd1, whereas nu-
cleotide substitutions in the stem of h27 (18S central h27
substitution) did not alter binding (Figure 6D). The sub-
stitutions changed the GGC nucleotides at position 1126–
1128 to UAA, while compensatory mutations allowed the
h27 stem to form. We tested a short RNA fragment cor-
responding to only h27, and this did not bind to Mrd1
(data not shown). In addition to the pre-rRNA fragments,
we tested whether full-length Mrd1 could bind in vitro to
any of the three snoRNAs, U3, U14 and snR30, which are
essential for processing of the 40S ribosomal subunit.
Neither the CRAC data nor our in vitro binding studies
convincingly showed binding to these snoRNAs (data not
shown). We conclude that in vitro, Mrd1 shows higher
afﬁnity for the ﬁrst two-thirds of 18S, including h27,
relative to other RNAs tested.
We analysed in vitro RNA binding of two separate
domains of Mrd1, an N-terminal domain containing
RBD1, 2 and 3 (RBD123) and a C-terminal domain con-
taining RBD 4 and 5 (RBD45). We also analysed binding
of the ﬁve individual RBDs. Binding of RBD123, as
compared to binding of RBD45, showed that the in vitro
binding speciﬁcity of Mrd1 is located within the
N-terminus of Mrd1 (Figure 6B). RBD123 exhibited ap-
proximately the same binding properties as full-length
Mrd1 (Figure 6B), including level of binding and Kd
values, but it also bound to the ITS1. Binding of
RBD123 to the 18S central constructs mimicked that of
full-length Mrd1. RBD123 did not bind to the h27
fragment (data not shown). We could not detect any sig-
niﬁcant binding of RBD45 or of any of the individual
RBDs to the tested RNA fragments.
We conclude that none of the isolated individual RBDs
binds RNA in vitro. However, in vitro RNA binding by
Mrd1 is observed for the ﬁrst three RBDs, including
linkers 1 and 2. This is in agreement with in vivo UV
cross-linking data for the RBD123 construct (Figure 4D)
and consistent with cooperative binding to the central
region of 18S rRNA.
Figure 6. The N-terminal part of Mrd1 binds to pre-rRNA in vitro. (A) Schematic ﬁgure of the 35S pre-rRNA. The lines indicate the RNA regions
used in the protein–RNA ﬁlter binding assays. (B) Percent RNA binding of Mrd1-GST and RBD123 to the indicated RNA regions. (C) Schematic
drawing of the synthetic RNA constructs of the 18S central domain, the h27 deletion (h27) and helix 27 substitution (h27 substitution). (D) Percent
RNA binding of Mrd1-GST and RBD123 to the 18S central constructs.
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DISCUSSION
Mrd1 is essential for synthesis of the pre-40S subunit and
is required for the A0–A2 cleavages of 35S pre-rRNA. The
unusual domain structure of Mrd1, with ﬁve RBDs, sug-
gested that it might play an important role in coordinating
events at different sites in the pre-rRNA during the early
steps in ribosome synthesis. Previous data revealed that
Mrd1 localizes to the nucleolus, co-precipitates 35S
pre-rRNA and co-sediments with 80–90S pre-ribosomes
(17,18). Our tandem afﬁnity puriﬁcations and proteomic
analyses demonstrated that Mrd1 is indeed incorporated
into early 90S pre-ribosomes. Analyses of deletion
mutants showed that Mrd1 lacking RBD1, 3 or 5 retains
the ability to bind pre-ribosomes; however, changes in
co-precipitated proteins indicate that these particles are
structurally abnormal and/or less stable than complexes
formed with wilt-type Mrd1. We conclude that Mrd1
indeed plays a role in the correct assembly of the early
pre-ribosomes.
Cross-linking (CRAC) data revealed two Mrd1 binding
sites, both located within the 18S rRNA region. No inter-
actions in the transcribed spacer regions were identiﬁed.
There are no indications that Mrd1 is associated with
mature 18S rRNA or 40S ribosomal subunits (data not
shown), and we therefore conclude that the CRAC results
revealed interactions between Mrd1 and pre-rRNA. The
precise sites of interaction in the 18S region were mapped
based on substitutions/deletions, to nucleotides 1126 and
1128 in h27 and nucleotide 1626 in h28. Both of these 18S
rRNA regions are functionally important in the mature
18S rRNA, and both are in close proximity to the
central pseudoknot (Figure 2D). The pseudoknot is a uni-
versal long-range interaction that is required for small
ribosomal subunit function (31,32). We therefore specu-
late that Mrd1 plays a role in promoting or regulating
formation of the pseudoknot within early pre-ribosomes,
acting in cooperation with other factors, including the U3
snoRNP. The early cleavages of the pre-rRNA, releasing
the pre-40S ribosome, are predominantly co-transcrip-
tional and are preceded by compaction of the nascent
transcript (5,6). The location of the Mrd1 binding sites
is in agreement with its requirement for the cleavages
and for a role in compaction of the pre-ribosome before
cleavage (18).
Binding sites for pre-40S subunit synthesis factors have
been mapped using CRAC (33). This revealed binding of
Tsr1 at regions surrounding h27, but, in contrast to Mrd1,
Tsr1 cross-linking did not generate mutations within h27.
Instead, nucleotides 1143–1146 show mutations in cDNAs
recovered with Tsr1, which is present in the nucleolus but
acts in pre-40S maturation after formation of 20S
pre-rRNA (34). Tsr1 is, therefore, likely to associate
with the pre-40S particles following dissociation of
Mrd1. Another factor, Dim1, associates with both the
90S and 40S pre-ribosomes. CRAC analysis located
Dim1 binding to the h28 region, but on the opposite
side of the duplex from the Mrd1 binding site. Dim1
also binds across the central pseudoknot (h2 and h28, nu-
cleotides 1137–1156), interaction sites that suggest a role
in pseudoknot formation (33).
The U3 snoRNP is required for the A0–A2 cleavages of
35S pre-rRNA (9) and base pairs with two sites in the
pre-rRNA 50 ETS (14,35), the 50 side of the pseudoknot
(10,36) and two sequences close to the 30 side of the
pseudoknot (37). The pseudoknot forms between helix 1
in the 50 end of 18S rRNA, forming the 50 side of the
pseudoknot, and the 30 side is located about 1140 nt down-
stream of helix 1. The pseudoknot involves only 3 bp;
therefore, for its formation, the two sides of the
pseudoknot probably need to be initially aligned by
other factors within the pre-ribosome. Little is known
about when and how this occurs, but the pseudoknot
fold is a key, and most likely irreversible, step during
subunit maturation, and the timing of its formation
must therefore be strictly controlled. U3 snoRNA may
participate in interactions that bring the 50 and 30 sides
of the pseudoknot into contact, but would need to be
released before pseudoknot formation.
The CRAC results demonstrated that Mrd1 is pos-
itioned close to the 30 side of the central pseudoknot, po-
tentially facilitating its formation. In the absence of Mrd1,
U3 snoRNA is recruited to pre-ribosomes (17), but its
release from base pairing with 35S pre-rRNA is inhibited
(18). CRAC experiments did not reveal direct association
between Mrd1 and U3, but deletion of individual RBDs
altered the association of U3-associated proteins Utp10
and Utp22 with the pre-ribosomes. This suggests that
the role of Mrd1 in U3 release is either indirect, perhaps
owing to alterations in pre-ribosome structure, or involves
interactions only with the protein components of the U3
snoRNP.
It is likely that the RBDs within Mrd1 are functionally
coordinated as suggested by the fact that they all contrib-
ute to the essential function of Mrd1 (18). The individual
RBDs in Mrd1 exhibited low RNA binding afﬁnity to
pre-rRNA sequences suggesting that, as for other
RNA-binding proteins built from multiple domains, the
modular structure is important for regulating binding spe-
ciﬁcity and activity (38). The deletion versions of Mrd1
were notably stable, in particular when RBD1 is
retained (Figure 4B). Each RBD in Mrd1 is likely to
have its speciﬁc version of the conserved typical RBD
structure. During evolution, the number of RBDs in
Mrd1 homologues has changed between four and six
(39), but the identity of individual RBDs has been
conserved (39). Functional analyses show the importance
of each RBD (18), supporting the model that each RBD
plays a speciﬁc role, although with some coupling.
Together with the observed stability of the deletion
versions of Mrd1, this indicates a modular design in
which functionally distinct RBDs are folded independent
of each other in the typical RBD fold, while the linker
domains are unstructured.
RBD123 is sufﬁcient for positioning Mrd1 close to the
30 side of the pseudoknot. Although RBD1 and RBD3 are
dispensable for interaction at h27, RBD2 is required for
efﬁcient interaction at h27 but not at h28. In the absence
of RBD2, Mrd1 interacts with h27 to a reduced extent,
and shows changes in the mutation frequency that indi-
cates an altered mode of binding. This implies that other
parts of Mrd1 can interact with h27 in the absence of
1188 Nucleic Acids Research, 2013, Vol. 41, No. 2
RBD2, although less efﬁciently. We postulate that RBD2
is normally responsible for direct recognition of h27. In
the absence of RBD2, other RBDs continue to interact
with h28 and still position the protein in association
with h27. Under these conditions, the interaction with
h27 may be more transient, or less tight leading to the
observed reduction in cross-linking, but is apparently suf-
ﬁcient to support ribosome synthesis, as the RBD2
mutant is viable. RBD2 is not required for the association
of Mrd1 with h28, but our analyses did not identify the
speciﬁc domain(s) of Mrd1 responsible for this inter-
action. As deletion of RBD2 leads to reduced cleavages
at A0–A2 and reduced synthesis of mature 18S rRNA, the
interaction at h27 appears functionally important.
Mrd1 must, however, have other functionally important
features, as RBD3 and RBD5 Mrd1 proteins still
interact at h27 but do not support productive ribosome
synthesis (18). Mrd1 that lacks RBD3 or especially RBD5
locks base paired U3 snoRNA into stalled pre-rRNP
complexes (18). This suggests that RBD3 and RBD5
participate in structural rearrangements in the pre-
ribosome and/or interactions with the U3 snoRNP that
lead to U3 eviction and pseudoknot formation. These
additional interactions are likely to coordinate structures
and/or factors at sites in close proximity in space in the
pre-ribosome that are crucial for pseudoknot formation
and pre-rRNA cleavage.
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